PL345064A1 - Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty - Google Patents

Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Info

Publication number
PL345064A1
PL345064A1 PL99345064A PL34506499A PL345064A1 PL 345064 A1 PL345064 A1 PL 345064A1 PL 99345064 A PL99345064 A PL 99345064A PL 34506499 A PL34506499 A PL 34506499A PL 345064 A1 PL345064 A1 PL 345064A1
Authority
PL
Poland
Prior art keywords
ghs
serm
selective
growth hormone
estrogen receptor
Prior art date
Application number
PL99345064A
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PL345064A1 publication Critical patent/PL345064A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL99345064A 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty PL345064A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
PL345064A1 true PL345064A1 (en) 2001-11-19

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99345064A PL345064A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Country Status (29)

Country Link
EP (1) EP1085867A1 (en)
JP (1) JP2002518328A (en)
KR (1) KR20010052817A (en)
CN (1) CN1305378A (en)
AP (1) AP9901581A0 (en)
AR (1) AR018868A1 (en)
AU (1) AU3342099A (en)
BG (1) BG105128A (en)
BR (1) BR9911357A (en)
CA (1) CA2335112A1 (en)
CO (1) CO5070586A1 (en)
EA (1) EA200001189A1 (en)
GT (1) GT199900083A (en)
HR (1) HRP20000857A2 (en)
HU (1) HUP0102395A2 (en)
ID (1) ID26726A (en)
IL (1) IL139587A0 (en)
IS (1) IS5727A (en)
MA (1) MA26648A1 (en)
NO (1) NO20006381D0 (en)
OA (1) OA11569A (en)
PA (1) PA8472101A1 (en)
PE (1) PE20000633A1 (en)
PL (1) PL345064A1 (en)
SK (1) SK18902000A3 (en)
TN (1) TNSN99118A1 (en)
UY (1) UY25557A1 (en)
WO (1) WO1999065488A1 (en)
ZA (1) ZA993973B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
BR0113626A (en) * 2000-08-30 2003-06-17 Pfizer Prod Inc Sustained-Release Formulations for Growth Hormone Secretors
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CN100548283C (en) * 2001-11-29 2009-10-14 Gtx公司 Osteoporosis prevention that androgen-deprivation causes and treatment
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
BRPI0807046A2 (en) 2007-02-09 2015-05-26 Tranzyme Pharma Inc Compound, pharmaceutical composition, methods of treating a disorder, cardiovascular disease and a patient suffering from reduced or dysfunctional gastrointestinal motility and, kit.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (en) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS

Also Published As

Publication number Publication date
ZA993973B (en) 2000-12-15
TNSN99118A1 (en) 2005-11-10
EP1085867A1 (en) 2001-03-28
IL139587A0 (en) 2002-02-10
AP9901581A0 (en) 1999-06-30
AU3342099A (en) 2000-01-05
CN1305378A (en) 2001-07-25
MA26648A1 (en) 2004-12-20
JP2002518328A (en) 2002-06-25
PE20000633A1 (en) 2000-07-26
NO20006381L (en) 2000-12-14
CO5070586A1 (en) 2001-08-28
OA11569A (en) 2004-07-01
WO1999065488A1 (en) 1999-12-23
BG105128A (en) 2001-11-30
HUP0102395A2 (en) 2001-11-28
BR9911357A (en) 2001-03-13
NO20006381D0 (en) 2000-12-14
EA200001189A1 (en) 2001-06-25
KR20010052817A (en) 2001-06-25
GT199900083A (en) 2000-12-05
SK18902000A3 (en) 2001-12-03
UY25557A1 (en) 2001-01-31
ID26726A (en) 2001-02-01
HRP20000857A2 (en) 2001-10-31
IS5727A (en) 2000-11-24
AR018868A1 (en) 2001-12-12
PA8472101A1 (en) 2000-09-29
CA2335112A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
IL145937A0 (en) Methods and apparatus for secure distribution of software
GB9601049D0 (en) Methods of and apparatus for forming nozzles
HUP0104993A3 (en) Method and device for controlled delivery of active agents
EP1003450A4 (en) Method and apparatus for inducing hypothermia
HUP0102951A3 (en) Apparatus for treatment of meniere's disease and similar conditions
PL336701A1 (en) Treatment of central nervous system diseases using selective modulators of oestrogen receptors
PL344981A1 (en) Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
PL345064A1 (en) Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
GB2326358B (en) Improved positioning device for concave of cone crusher
PL345588A1 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
HUP0003340A3 (en) Process and apparatus for preparation of vesicles
PL339365A1 (en) Apparatus for and method of feeding pieces of cake
IL147008A0 (en) Mixing apparatus and method of mixing
PL336422A1 (en) Method of and apparatus for preparing asphalt mixes
DK0931454T3 (en) Apparatus for comminution and mixing of animal feed components
GB2319519B (en) Adjustment of mosaic spread for HOPG material
IL117770A0 (en) Method and apparatus for growing of extended crystals
GB9717211D0 (en) Improvements relating to means of controlling different apparatus
PL335477A1 (en) Method of and apparatus for controlling operation of snow removing mixture spreader
GB9817579D0 (en) Method of and apparatus for controlling headway
HU9801165D0 (en) Process and apparatus for fire-prevention of cable-lines and this protekted cable-line
GB9908411D0 (en) Method and apparatus for controlled distribution of supports in combinatorial synthesis
IL132369A0 (en) Method of treatment of scalp and hair and formulations for implementation of this method
PL337444A1 (en) Method of and apparatus for meteringly dispensing predetermined portions of material
TW362757U (en) Improvement for protection apparatus of water heater